These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2659417

  • 21. Treatment of gastro-oesophageal reflux and gastric stasis: new perspectives with cisapride. Proceedings of a symposium of the 13th International Congress of Gastroenterology. Rome, 6 September 1988.
    Scand J Gastroenterol Suppl; 1989; 165():1-65. PubMed ID: 2602909
    [No Abstract] [Full Text] [Related]

  • 22. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B, Greving I.
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [Abstract] [Full Text] [Related]

  • 23. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.
    Maddern GJ, Jamieson GG, Myers JC, Collins PJ.
    Gut; 1991 May; 32(5):470-4. PubMed ID: 2040466
    [Abstract] [Full Text] [Related]

  • 24. Cisapride--more selective than metoclopramide.
    Drug Ther Bull; 1990 Nov 12; 28(23):89-90. PubMed ID: 2131232
    [No Abstract] [Full Text] [Related]

  • 25. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG, Berstad A.
    Tidsskr Nor Laegeforen; 1994 Feb 28; 114(6):689-92. PubMed ID: 8191452
    [Abstract] [Full Text] [Related]

  • 26. Effect of cisapride on gastric motility.
    Schuurkes J.
    Z Gastroenterol; 1990 Apr 28; 28 Suppl 1():27-30; discussion 44. PubMed ID: 2356634
    [Abstract] [Full Text] [Related]

  • 27. Diagnosis and treatment of delayed gastric emptying.
    Ricci DA, McCallum RW.
    Adv Intern Med; 1988 Apr 28; 33():357-84. PubMed ID: 3278511
    [No Abstract] [Full Text] [Related]

  • 28. Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients.
    Tatsuta M, Iishi H, Nakaizumi A, Okuda S.
    Aliment Pharmacol Ther; 1992 Apr 28; 6(2):221-8. PubMed ID: 1600042
    [Abstract] [Full Text] [Related]

  • 29. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW.
    Am J Gastroenterol; 1985 Dec 28; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract] [Full Text] [Related]

  • 30. Cisapride and gastric emptying of a solid meal in dyspeptic diabetics without autonomic neuropathy and in healthy volunteers.
    Brogna A, Ferrara R, Scornavacca G, Lombardo A, Bucceri A, Catalano F, Paradisi V, Onorato S.
    Eur J Clin Pharmacol; 1989 Dec 28; 37(4):411-3. PubMed ID: 2598976
    [Abstract] [Full Text] [Related]

  • 31. Drug therapy. Metoclopramide.
    Schulze-Delrieu K.
    N Engl J Med; 1981 Jul 02; 305(1):28-33. PubMed ID: 7015140
    [No Abstract] [Full Text] [Related]

  • 32. Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology.
    McCallum RW.
    Am J Gastroenterol; 1991 Feb 02; 86(2):135-49. PubMed ID: 1992624
    [No Abstract] [Full Text] [Related]

  • 33. Prokinetic agents: a key in the future of gastroenterology.
    Reynolds JC.
    Gastroenterol Clin North Am; 1989 Jun 02; 18(2):437-57. PubMed ID: 2668178
    [Abstract] [Full Text] [Related]

  • 34. Clinical use of cisapride and its risk-benefit in paediatric patients.
    Vandenplas Y.
    Eur J Gastroenterol Hepatol; 1998 Oct 02; 10(10):871-81. PubMed ID: 9831411
    [Abstract] [Full Text] [Related]

  • 35. [Prokinetic drugs].
    Hellström P.
    Nord Med; 1992 Oct 02; 107(11):274-7. PubMed ID: 1448341
    [Abstract] [Full Text] [Related]

  • 36. Cisapride therapy for gastrointestinal disease.
    Cucchiara S.
    J Pediatr Gastroenterol Nutr; 1996 Apr 02; 22(3):259-69. PubMed ID: 8708879
    [No Abstract] [Full Text] [Related]

  • 37. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ, Spence RA, Ferguson R, Laird J, Love AH.
    Hepatogastroenterology; 1987 Jun 02; 34(3):113-6. PubMed ID: 3301606
    [Abstract] [Full Text] [Related]

  • 38. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
    Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR.
    Gastroenterology; 1989 Mar 02; 96(3):704-12. PubMed ID: 2644150
    [Abstract] [Full Text] [Related]

  • 39. A double-blind fluoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia.
    Degryse H, De Schepper A, Verlinden M.
    Scand J Gastroenterol Suppl; 1993 Mar 02; 195():1-4. PubMed ID: 8516652
    [Abstract] [Full Text] [Related]

  • 40. Cisapride for severe non-ulcer dyspepsia, pseudoobstruction and constipation.
    Graham JR.
    Med J Aust; 1989 Jun 05; 150(11):667. PubMed ID: 2725385
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.